HomeCDXS • NASDAQ
add
Codexis Inc
Previous close
$2.92
Day range
$2.75 - $3.01
Year range
$2.43 - $6.08
Market cap
232.77M USD
Avg Volume
1.01M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 21.46M | -19.20% |
Operating expense | 13.05M | 7.09% |
Net income | -10.38M | -44.27% |
Net profit margin | -48.35 | -78.55% |
Earnings per share | -0.13 | -25.60% |
EBITDA | -6.13M | -509.62% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 73.46M | 12.81% |
Total assets | 149.01M | 9.12% |
Total liabilities | 82.08M | 64.35% |
Total equity | 66.93M | — |
Shares outstanding | 82.84M | — |
Price to book | 3.56 | — |
Return on assets | -12.35% | — |
Return on capital | -15.16% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -10.38M | -44.27% |
Cash from operations | -16.47M | -49.21% |
Cash from investing | -2.86M | -359.33% |
Cash from financing | 1.13M | — |
Net change in cash | -18.20M | -83.22% |
Free cash flow | -12.95M | -393.17% |
About
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. Wikipedia
CEO
Founded
2002
Headquarters
Website
Employees
188
